 Kieuhoa Vo, MD
|
| Title(s) | Assistant Professor, Pediatrics |
|---|
| School | School of Medicine |
|---|
| Address | 550 16th. Street
San Francisco CA 94158
|
|---|
| Phone | 415-476-3831 |
|---|
| vCard | Download vCard |
|---|
|
|
 Biography | University of Notre Dame | B.S., Biological Sciences | 2004 | | | Indiana University School of Medicine | M.D. | 2008 | | | Nationwide Children's Hospital | Pediatric Residency | 2011 | | | University of California, San Francisco | M.A.S., Clinical Research | 2015 | | | University of California, San Francisco | Pediatric Oncology/Hematology Fellowship | 2015 | |
ORNG Applications Bibliographic
Altmetrics Details
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media.
(Note that publications are often cited in additional ways that are not shown here.)
Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication.
Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication.
Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.)
Click a Field or Translation tag to filter the publications.
-
Association of image-defined risk factors with clinical features, histopathology, and outcomes in neuroblastoma. Cancer Med. 2020 Dec 13.
Temple WC, Vo KT, Matthay KK, Balliu B, Coleman C, Michlitsch J, Phelps A, Behr S, Zapala MA. PMID: 33314708.
View in: PubMed Mentions: Fields:
-
Phase I trial of pazopanib in combination with irinotecan and temozolomide (PAZIT) for children and young adults with advanced sarcoma. Journal of Clinical Oncology. 2020 May 20; 38(15_suppl):10526-10526.
Kieuhoa T. Vo, Jennifer G. Michlitsch, Avanthi T. Shah, Joel M. Reid, Sarah A. Burhow, Eloise M. Graham, Fabienne Hollinger, Matthew A. Zapala, Janel Long-Boyle, Mi-Ok Kim, Katherine K. Matthay, Steven G. DuBois. .
View in: Publisher Site Mentions:
-
124I-MIBG PET/CT to Monitor Metastatic Disease in Children with Relapsed Neuroblastoma. J Nucl Med. 2021 Jan; 62(1):43-47.
Aboian MS, Huang SY, Hernandez-Pampaloni M, Hawkins RA, VanBrocklin HF, Huh Y, Vo KT, Gustafson WC, Matthay KK, Seo Y. PMID: 32414950.
View in: PubMed Mentions: 2 Fields:
-
Precision Medicine in Pediatric Oncology. Surg Oncol Clin N Am. 2020 01; 29(1):63-72.
Vo KT, Parsons DW, Seibel NL. PMID: 31757314.
View in: PubMed Mentions: 2 Fields:
-
Risk Factors for Transplant-Associated Thrombotic Microangiopathy after Autologous Hematopoietic Cell Transplant in High-Risk Neuroblastoma. Biol Blood Marrow Transplant. 2019 10; 25(10):2031-2039.
Tolbert VP, Dvorak CC, Golden C, Vissa M, El-Haj N, Perwad F, Matthay KK, Vo KT. PMID: 31199983.
View in: PubMed Mentions: Fields: Translation: Humans
-
Technical Note: Simplified and practical pretherapy tumor dosimetry - A feasibility study for 131 I-MIBG therapy of neuroblastoma using 124 I-MIBG PET/CT. Med Phys. 2019 May; 46(5):2477-2486.
Seo Y, Huh Y, Huang SY, Hernandez-Pampaloni JM, Hawkins RA, Gustafson WC, Vo KT, Matthay KK. PMID: 30761545.
View in: PubMed Mentions: 1 Fields: Translation: Humans
-
Detection of circulating tumour DNA is associated with inferior outcomes in Ewing sarcoma and osteosarcoma: a report from the Children's Oncology Group. Br J Cancer. 2018 08; 119(5):615-621.
Shulman DS, Klega K, Imamovic-Tuco A, Clapp A, Nag A, Thorner AR, Van Allen E, Ha G, Lessnick SL, Gorlick R, Janeway KA, Leavey PJ, Mascarenhas L, London WB, Vo KT, Stegmaier K, Hall D, Krailo MD, Barkauskas DA, DuBois SG, Crompton BD. PMID: 30131550.
View in: PubMed Mentions: 12 Fields: Translation: Humans
-
Phase 1 study of sirolimus in combination with oral cyclophosphamide and topotecan in children and young adults with relapsed and refractory solid tumors. Oncotarget. 2017 Apr 04; 8(14):23851-23861.
PMID: 27793021.
View in: PubMed Mentions: 1 Fields: Translation: HumansCTClinical Trials
-
Incidence and risk factors for secondary malignancy in patients with neuroblastoma after treatment with (131)I-metaiodobenzylguanidine. Eur J Cancer. 2016 10; 66:144-52.
PMID: 27573428.
View in: PubMed Mentions: 4 Fields: Translation: HumansCTClinical Trials
-
Targeted antiangiogenic agents in combination with cytotoxic chemotherapy in preclinical and clinical studies in sarcoma. Clin Sarcoma Res. 2016; 6:9.
PMID: 27274393.
View in: PubMed Mentions:
-
Conditional Survival and Predictors of Late Death in Patients With Ewing Sarcoma. Pediatr Blood Cancer. 2016 Jun; 63(6):1091-5.
PMID: 26891183.
View in: PubMed Mentions: 5 Fields: Translation: Humans
-
Impact of Two Measures of Micrometastatic Disease on Clinical Outcomes in Patients with Newly Diagnosed Ewing Sarcoma: A Report from the Children's Oncology Group. Clin Cancer Res. 2016 07 15; 22(14):3643-50.
PMID: 26861456.
View in: PubMed Mentions: 4 Fields: Translation: Humans
-
Identification of patient subgroups with markedly disparate rates of MYCN amplification in neuroblastoma: A report from the International Neuroblastoma Risk Group project. Cancer. 2016 Mar 15; 122(6):935-45.
PMID: 26709890.
View in: PubMed Mentions: 17 Fields: Translation: Humans
-
Clinical, biologic, and prognostic differences on the basis of primary tumor site in neuroblastoma: a report from the international neuroblastoma risk group project. J Clin Oncol. 2014 Oct 01; 32(28):3169-76.
PMID: 25154816.
View in: PubMed Mentions: 27 Fields: Translation: Humans
-
Menstrual bleeding patterns and prevalence of bleeding disorders in a multidisciplinary adolescent haematology clinic. Haemophilia. 2013 Jan; 19(1):71-5.
PMID: 23005346.
View in: PubMed Mentions: 7 Fields: Translation: Humans
This graph shows the total number of publications by year. To see the data as text, click here.
This graph shows the total number of publications by year. To return to the graph, click here.
| Year | Publications |
|---|
| 2012 | 1 | | 2014 | 1 | | 2015 | 1 | | 2016 | 4 | | 2017 | 1 | | 2018 | 1 | | 2019 | 3 | | 2020 | 3 |
This graph shows the number and percent of publications by field.
Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications.
Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written.
To see the data as text, click here.
This graph shows the number and percent of publications by field.
Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications.
Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written.
To see the data as text, click here.
newest
oldest
line numbers
double spacing
all authors
publication IDs
|
Derived automatically from this person's publications.
_
People in Profiles who have published with this person.
_
People who share similar concepts with this person.
_
Search Department
_
|